Karuna Therapeutics, Inc.
🏢 View company profile →7Patents
7Active
7Granted
48Portfolio score
Filing activity: Sep 27, 2019 → Jun 11, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10933020B2 | Compositions and methods for treating disorders ameliorated by muscarinic receptor activation | Human Necessities | 4 | Active |
| US10925832B2 | Compositions and methods for treatment of disorders ameliorated by muscarinic receptor activation | Human Necessities | 3 | Active |
| US11471413B2 | Compositions and methods for treating disorders ameliorated by muscarinic receptor activation | Human Necessities | 1 | Active |
| US11452692B2 | Compositions and methods for treating disorders ameliorated by muscarinic receptor activation | Human Necessities | 1 | Active |
| US12421242B2 | Substituted tetrahydropyrrolo-pyridinone compounds and their use in treating medical conditions | Chemistry; Metallurgy | 0 | Active |
| US11534434B2 | Xanomeline derivatives and methods for treating neurological disorders | Chemistry; Metallurgy | 0 | Active |
| US11890378B2 | Compositions and methods for treating disorders ameliorated by muscarinic receptor activation | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.